Cipla shines on inking pact with with Gilead Sciences

13 May 2020 Evaluate

Cipla is currently trading at Rs. 582.55, up by 12.55 points or 2.20% from its previous closing of Rs. 570.00 on the BSE.

The scrip opened at Rs. 603.50 and has touched a high and low of Rs. 603.50 and Rs. 574.75 respectively. So far 107977 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 632.05 on 27-Apr-2020 and a 52 week low of Rs. 356.75 on 13-Mar-2020.

Last one week high and low of the scrip stood at Rs. 603.50  and Rs. 566.25 respectively. The current market cap of the company is Rs. 45955.64 crore.

The promoters holding in the company stood at 36.68%, while Institutions and Non-Institutions held 41.17% and 22.16% respectively.

Cipla has signed a non-exclusive licensing agreement with Gilead Sciences, Inc. for the manufacturing and distribution of the investigational medicine Remdesivir, which has been issued an Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (USFDA) to treat COVID-19 patients. This agreement is part of company’s efforts to enhance global access to lifesaving treatments for patients affected by the pandemic.

As part of the agreement, Cipla will be permitted to manufacture the API and Finished product, and market it in 127 countries including India and South Africa under company’s own brand name. The company will receive the manufacturing know-how from Gilead Sciences, Inc. to manufacture the API and Finished product at a commercial scale. The company’s extensive geographical and commercial footprint will help make this therapy accessible to more patients and markets.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1324.00 3.65 (0.28%)
30-Jan-2026 12:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1597.00
Dr. Reddys Lab 1218.90
Cipla 1324.00
Zydus Lifesciences 886.55
Lupin 2140.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×